VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 231,845,620
- Share change
- -8,677,387
- Total reported value
- $90,712,440,433
- Put/Call ratio
- 65%
- Price per share
- $391.64
- Number of holders
- 1,507
- Value change
- -$3,681,628,852
- Number of buys
- 677
- Number of sells
- 765
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13D/G
13F
|
Company |
11%
|
28,739,975
|
$14,470,577,412 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
23,973,777
|
$10,673,125,520 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.6%
|
21,871,945
|
$9,737,389,761 | — | 30 Jun 2025 | |
| Capital Research Global Investors |
13F
|
Company |
6.3%
|
16,108,291
|
$7,171,363,823 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
11,775,227
|
$5,242,331,060 | — | 30 Jun 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.6%
|
9,220,827
|
$4,642,686,284 | $0 | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.4%
|
6,151,505
|
$2,738,650,167 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
5,928,747
|
$2,627,134,533 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
5,869,361
|
$2,613,065,480 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.9%
|
4,813,386
|
$2,142,919,447 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.7%
|
4,378,320
|
$1,949,228,064 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.5%
|
3,813,378
|
$1,697,715,954 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
3,580,356
|
$1,593,974,491 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
3,331,439
|
$1,483,157,862 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
3,159,870
|
$1,406,775,000 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
3,067,473
|
$1,365,638,980 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
2,807,617
|
$1,249,951,227 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,658,581
|
$1,183,600,261 | — | 30 Jun 2025 | |
| Capital International Investors |
13F
|
Company |
1%
|
2,635,903
|
$1,173,391,783 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1%
|
2,619,534
|
$1,166,208,878 | — | 30 Jun 2025 | |
| EDGEWOOD MANAGEMENT LLC |
13F
|
Company |
0.96%
|
2,454,947
|
$1,092,942,404 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.86%
|
2,181,362
|
$971,133,856 | — | 30 Jun 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.85%
|
2,155,164
|
$967,776,686 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.78%
|
1,984,046
|
$883,297,138 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.76%
|
1,931,760
|
$860,019,592 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.74%
|
1,889,777
|
$841,328,720 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
1,773,625
|
$789,617,850 | — | 30 Jun 2025 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
0.67%
|
1,711,440
|
$761,933,088 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.63%
|
1,600,473
|
$712,530,562 | — | 30 Jun 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.6%
|
1,527,864
|
$680,204,861 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.55%
|
1,407,634
|
$626,678,657 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.54%
|
1,384,368
|
$616,320,000 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.5%
|
1,284,354
|
$571,794,401 | — | 30 Jun 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.47%
|
1,205,796
|
$536,820,298 | — | 30 Jun 2025 | |
| Amundi |
13F
|
Individual |
0.44%
|
1,133,226
|
$517,918,279 | — | 30 Jun 2025 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
1,163,670
|
$513,527,571 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.42%
|
1,062,235
|
$472,907,021 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.39%
|
1,004,888
|
$447,376,138 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.32%
|
822,937
|
$366,371,552 | — | 30 Jun 2025 | |
| Swiss National Bank |
13F
|
Company |
0.31%
|
778,300
|
$346,499,160 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.29%
|
735,822
|
$326,982,706 | — | 30 Jun 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.28%
|
725,055
|
$322,794,486 | — | 30 Jun 2025 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.28%
|
711,611
|
$316,823,713 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.28%
|
702,052
|
$312,553,617 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
700,002
|
$311,640,891 | — | 30 Jun 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
699,644
|
$310,894,661 | — | 30 Jun 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
655,050
|
$291,628,260 | — | 30 Jun 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.26%
|
650,259
|
$289,495,307 | — | 30 Jun 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.25%
|
641,961
|
$285,726,850 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
599,079
|
$266,709,971 | — | 30 Jun 2025 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2025
As of 30 Sep 2025,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,507 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
231,845,620 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, and ALLIANCEBERNSTEIN L.P..
This page lists
1,508
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
1,543
Q3 2025 holders
1,507
Holder diff
-36
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.